Security key
60770K107
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 84,483,070
- Total 13F value
- $1,235,871,867
- Share change
- +9,794,410
- Put/Call ratio
- 37%
- SEC-reported price per share
- $14.64
- Number of holders
- 128
- Value change
- +$117,389,510
- Number of buys
- 90
- Number of sells
- 40
- Shares outstanding
- 397,148,913
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2019
Institutions
128
Top holders
10
MRNA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2019
Previous quarter: Q1 2019
Moderna, Inc. SEC filings
Moderna, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 60770K107
Recent filing periods:
Ownership snapshot
Top reported holders of MRNA - Moderna, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Flagship Pioneering, LLC
Disclosed value leader
VIKING GLOBAL INVESTORS LP
Comparable rows
15/15
Latest evidence
31 Mar 2019
13F
Lead comparable stake: 15%
Showing 1-6 of 15 holder rows.
Quick read
Flagship Pioneering, LLC leads the comparable SEC ownership view at 15%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Flagship Pioneering, LLC's linked filing trail.
Comparable ownership
Top 5
Flagship Pioneering, LLC
15%
VIKING GLOBAL INVESTORS LP
4.2%
FMR LLC
3.8%
Artal Group S.A.
1.3%
BB BIOTECH AG
1.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Flagship Pioneering, LLC |
13F
Company
|
15%
|
$1,196,730
58,807,379 shares
|
— | 31 Mar 2019 |
| VIKING GLOBAL INVESTORS LP |
13F
Company
|
4.2%
|
$339,191,000
16,667,866 shares
|
— | 31 Mar 2019 |
| FMR LLC |
13F
Company
|
3.8%
|
$296,225,000
15,214,205 shares
|
— | 31 Mar 2019 |
| Artal Group S.A. |
13F
Company
|
1.3%
|
$101,878,000
5,006,298 shares
|
— | 31 Mar 2019 |
| BB BIOTECH AG |
13F
Company
|
1.2%
|
$97,389,000
4,785,681 shares
|
— | 31 Mar 2019 |
| FIDUCIARY TRUST CO |
13F
Company
|
1.1%
|
$87,748,000
4,311,926 shares
|
— | 31 Mar 2019 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2019
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
128
Shares
84,483,070
Rows available
128
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2019 vs Q1 2019 Across Filers
Q1 2019 holders
101
Q2 2019 holders
128
Holder diff
27
| Investor | Q1 2019 Shares | Q2 2019 Shares | Share Diff | Share Chg % | Q1 2019 value | Q2 2019 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend